Sartorius Aktiengesellscha (Germany) Today
| SRT3 Stock | 211.10 7.10 3.48% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Sartorius Aktiengesellscha is trading at 211.10 as of the 23rd of November 2024, a 3.48 percent up since the beginning of the trading day. The stock's lowest day price was 205.6. Sartorius Aktiengesellscha has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sartorius Aktiengesellschaft are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of November 2023 and ending today, the 23rd of November 2024. Click here to learn more.
Moving against Sartorius Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sartorius Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sartorius Aktiengesellscha's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sartorius Aktiengesellscha or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Sartorius Aktiengesellschaft (SRT3) is traded on XETRA Stock Exchange in Germany and employs 15,942 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 23.84 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sartorius Aktiengesellscha's market, we take the total number of its shares issued and multiply it by Sartorius Aktiengesellscha's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sartorius Aktiengesellscha operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 34.19 M outstanding shares.
Sartorius Aktiengesellschaft has accumulated about 342.81 M in cash with 734.2 M of positive cash flow from operations.
Check Sartorius Aktiengesellscha Probability Of Bankruptcy
Ownership AllocationSartorius Aktiengesellscha shows a total of 34.19 Million outstanding shares. Sartorius Aktiengesellscha maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sartorius Ownership Details
Sartorius Aktiengesellscha Risk Profiles
Although Sartorius Aktiengesellscha's alpha and beta are two of the key measurements used to evaluate Sartorius Aktiengesellscha's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.96 | |||
| Standard Deviation | 3.19 | |||
| Variance | 10.16 | |||
| Risk Adjusted Performance | (0.03) |
Sartorius Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sartorius Aktiengesellscha without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Sartorius Aktiengesellscha Corporate Management
Elected by the shareholders, the Sartorius Aktiengesellscha's board of directors comprises two types of representatives: Sartorius Aktiengesellscha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Aktiengesellscha's management team and ensure that shareholders' interests are well served. Sartorius Aktiengesellscha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Aktiengesellscha's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rene Faber | Head Board | Profile | |
| Petra Kirchhoff | Head Board | Profile | |
| Rashid Maqbool | Head USA | Profile | |
| Manfred Werner | Sr Auditing | Profile | |
| Mei Wang | Head China | Profile | |
| Patricia Spannagel | Head Goettingen | Profile | |
| Joachim Kreuzburg | Chairman CEO | Profile |
Other Information on Investing in Sartorius Stock
Sartorius Aktiengesellscha financial ratios help investors to determine whether Sartorius Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Aktiengesellscha security.